Pfizer Inc. general counsel Amy Schulman picked up some new responsibilities this week in the wake of former CEO Jeffrey Kindler’s abrupt resignation on Dec. 5.
As part of an executive team shake-up by new CEO Ian Read on Tuesday, Schulman has been put in charge of the pharmaceutical giant’s nutrition business unit, which was acquired as part of Pfizer’s takeover of Wyeth Pharmaceuticals Inc. The nutrition business’ product portfolio includes a full line of infant formulas and other nutritional products for children.
